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POSITION PIECES 
Living with transplant 
Never quite beyond illness 
Laura L. Heinemann 
Abstract  
Organ transplantation is often held to epitomize the power and promise of biomedicine. Yet 
life after transplant does not so clearly mark an ‘after’ to illness, and instead requires close 
monitoring and treating for organ rejection, graft failure, or the side effects of medication 
regimens. Such medical domains are counterbalanced, in turn, by relations of kinship, 
friendship, home and work life. In this Position Piece, I call for attention to the interconnected 
tensions among these domains, focusing on one illustrative case example: that of Janet, a three-
time kidney recipient. By detailing Janet’s lifelong imbrication of daily life with vulnerability 
and biomedical intervention, I delineate the mismatch between popular imaginings of 
transplant as ‘cure’ and the realities of living a life that is never quite beyond illness. 
Keywords  
organ transplant, post-transplant, medicine, complications 
Introduction 
Organ transplantation serves as one of the ‘crown jewels’ in what historian Emily Abel (2013, 
1) has called ‘medicine’s triumphal epic, which emphasizes the sensational advances that have 
rescued people from death’ (see also Kaufman 2015). It is widely held to allow loved ones – 
whether deceased organ donors or gravely ill recipients – to ‘live on’. Its curative possibilities 
epitomize the power and promise of biomedicine.  
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It follows, then, that transplant-related public discourse in the United States is saturated with 
powerful, pervasive forms of hope and consolation, revealed through human interest news 
stories, promotional materials meant to motivate potential organ donors, and advertising of 
regional health systems’ transplant programs. Taken together, almost as a genre, messages 
around transplant tend to follow a familiar narrative of dramatic transformation: the gravely 
ill patient becomes a thriving, active individual through high-tech medicine and the generosity 
of organ donors and their families (Scheper-Hughes 2007; Sharp 2006). Predictably, these 
messages are accompanied by images of people laughing with family members, returning to 
work, or walking through a verdant park with a friend or a partner – all thanks to a transplant.  
But, optimistic discourses notwithstanding, the lived realities of transplant are far more 
complicated. They take shape in the persistent tethers between the often counterposed 
domains of biomedicine and the everyday. One does not merely live a longer life because of 
transplant; rather, one lives with transplant while also living the ideals and realities of kinship, 
friendship, occupation, and leisure. The transplant endeavor relies on patients and their loved 
ones to weave together the myriad strands among these domains. While illness might be 
periodically obscured in the tangle, it is never truly severed from the experience of living with 
transplant. Thus, as one does what it takes to raise children, hold employment, care for elder 
kin, maintain friendships, play, and sustain a household while also taking medicine, managing 
side effects, monitoring lab values, and undergoing medical procedures, one is living with 
transplant and never quite beyond illness. In this sense, transplant living engages questions at 
the heart of this special issue: how do we de-center illness as a privileged category in medical 
anthropology without losing sight of its continued presence? How do we understand the 
relationship between biomedicine and the everyday when there is no ‘after’ to illness?  
As I detail throughout this Position Piece, transplant entails much more than the surgical 
imbrication of bodily tissues. Potential candidates learn quickly that the transplant process 
demands much: intensive evaluation and arduous pre-transplant procedures, emotional 
upheaval and moral uncertainties, a lifetime of reliance on expensive and complex medication 
regimens, and the very real possibility that it will all be in vain. Transplantation appeals not 
simply to hopes for a longer life, but to the restored possibility of engagement with the day-
to-day contexts of kinship, friendship, leisure, and occupation. Patients who might otherwise 
hesitate nevertheless turn toward transplant out of a sense of obligation to children or 
grandchildren, aging or infirm parents, or others who rely on them and suffer the ripple effects 
of their life-threatening illness (Heinemann 2014, 2016; see also Manderson 2011). For 
recipients, everyday living, rather than life itself, becomes the stake.  
But transplant recipients and clinicians alike point out that the procedure trades one set of 
problems for another: the difficulties of dialysis for the side effects of immunosuppressants; 
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the fears of organ failure for the fears of organ rejection. In best-case scenarios, there is no 
interruption in a recipient’s ability to take their myriad post-transplant medications, side effects 
are kept to a minimum or sufficiently mitigated with other therapeutics, infection is avoided, 
rejection kept in check, and a grafted organ maintains its functioning for several years. Yet, it 
is also possible that the transplant ‘fails’, the patient experiences post-surgical infection or 
other complications due to a suppressed immune system, obstacles arise to follow-up care, or 
that the grafted organ is lost to rejection. In these scenarios, a patient’s best hope is to re-
qualify – and return to the transplant waiting list (see Manderson 2011). Those recipients who 
live longer increasingly experience not only the celebrated benefits of transplant medicine, but 
also its more hidden cumulative detriments. Their lives are sustained by having received a 
transplant, but they also are constrained. ‘Held up’ in both senses of the phrase, they live in 
suspension. 
Over time, immunosuppressant medications can increase risks of cancer, osteoporosis, high 
blood pressure, diabetes, and other complications. If the ideal of a successful transplant is 
represented as life beyond the reaches of illness – a return to the ‘normal’ as envisioned by 
patients and loved ones – then the lived reality of transplantation reveals that normalcy is 
elusive (Wolf-Meyer 2014; see also Manderson 1999) and is tethered to the chronicities 
(Estroff 1993; Manderson and Smith-Morris 2010) of enduring medical intervention and 
monitoring (see Heinemann 2015).  
Below, I foreground some of the ways transplant belies the assumed curative potential of high-
tech biomedicine by looking closely to the experiences of Janet, a three-time kidney recipient. 
More specifically, I trace Janet’s lifelong imbrication of vulnerability and biomedical 
intervention with daily living and webs of relations, highlighting the persistent tethers (and 
their tensions) that in some ways sustain and in other ways suspend Janet over time. 
A suspended walk with Janet: Living with transplant in the long term 
Janet had been wanting to get out of the house. The weeks of winter had been wearing on her 
and her living space was already feeling smaller now that her elderly mother had moved in, 
joining Janet, her adult son, and her two dogs. Tired of feeling cooped up, she called one 
afternoon to see if I could join her for a matinee. After purchasing tickets and popcorn, we 
chatted while walking down the theater’s long hall. What funny things were my young sons 
saying these days? How was her mother feeling? How did my husband like his new job? 
What did she think of her son’s new girlfriend? But as we walked, Janet’s breathing became 
labored and her steps slower. She stopped talking and paused to lean on a railing. Making our 
way to sit down, I asked whether we needed to get some help. As in, medical help. But, 
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between breaths, and with an expression that said she meant business, she said no, we’re going 
to see this movie. 
I first met Janet – middle class, white, and nearing sixty years of age – in 2008 during one of 
her appointments in the outpatient solid organ transplant clinic of a major transplant center 
in the US Midwest. This site was the hub of my ethnographic study, which I conducted during 
twenty-four non-consecutive months from 2007 to 2010. My fieldwork included ethnographic 
interviews with transplant hopefuls, candidates, and recipients, as well as their loved ones and 
clinical professionals. I also gathered data through participant observation in inpatient and 
outpatient settings, participants’ homes, and other community spaces. My guiding questions 
sought insights into quotidian home life, kinship, care, and caregiving, as patients and loved 
ones made their way toward, through, and beyond transplantation. For some of my 
interlocutors, like Janet, biomedicine both permeated the everyday and folded into her fuller 
life course. 
That day at the movies, Janet was over a year out from her third kidney transplant. Congenital 
glomerulonephritis had caused her kidneys to lose function from the time she was an infant. 
By age eleven, physicians told her parents the kidney disease was so substantial and progressive 
that Janet would not live into adulthood. Partially true to prediction, her kidneys ceased 
functioning when she was nineteen.  
But renal transplant, while still rather new, was by that time a viable treatment option even 
where she lived, in the heart of the American Great Plains. By age twenty, in one of the first 
transplants performed in the state, Janet became, to borrow from Ronald Maynard (2006, 226), 
‘a living testimony to failed prognostication’. This kidney, a living donation from her father, 
fulfilled its intended purpose for about twenty years before Janet needed to return to the 
transplant waiting list. She received her second transplanted kidney from a deceased organ 
donor. The third was through a paired kidney exchange, or ‘swap’: Janet’s cousin, whose blood 
type was incompatible with Janet’s, donated her kidney to an anonymous person with whom 
she matched; this person’s incompatible living donor in turn donated a kidney to Janet, who 
was likewise an anonymous match. 
From her first transplant, Janet’s release from end-stage renal disease was only ever partial and 
temporary. She has needed dialysis in the weeks and months prior to each of her subsequent 
transplants. And beyond kidney disease, she has endured what Lenore Manderson and Narelle 
Warren (2016) call a ‘recursive cascade’ of ‘multiple chronic conditions’, many traced back to 
her decades-long reliance on anti-rejection, immunosuppressant medication regimens. The 
compounding side-effects of her post-transplant therapies included: cataracts from age 
twenty-seven; arthritis precipitated by an immunosuppressant discontinued thirty years ago; a 
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shoulder replacement due to arthritis; skin cancer, to which she is prone due to her 
medications; and, ironically, renal damage from the anti-rejection regimen itself.  
These multiplicative health matters were accompanied by a formidable stock of 
pharmacotherapies in Janet’s home, stored in a three-tiered plastic stack of drawers on rollers 
she once wheeled out for me to see. Each drawer was stocked with bottles of pills, liquids, 
creams, eye drops, and inhalers, measuring caps, organizers, tubes, gauze, scissors, and syringes 
– all used according to a complex prescribed schedule.  
But it would be inaccurate to frame this long list of conditions, and the piling on of medical 
interventions to address them, as straightforward evidence of Janet’s perpetual illness and 
inescapable patienthood. For one, Janet was as much a caregiver as she was a patient; on the 
very day we first met, she both received medical care as a patient in the transplant clinic and 
provided and coordinated care for her mother, who had been hospitalized following a recent 
fall. Further, health concerns did not, in fact, define her. Though she had recently gone on 
permanent disability support, she’d previously held a long career as a corporate trust 
administrator at a large regional bank. She owned a home for much of her adult life, had 
married then divorced, and adopted and raised a son. She led an active social life and enjoyed 
crafting decorative wreaths and bowls as a hobby. 
Tensions and tethers: Medicine and the everyday 
Janet’s experiences of living with transplant reveal the tensions and tethers between everyday 
life and medicine in the long term. Her walk to the movie theater that winter afternoon was 
slowed and suspended not by reduced kidney function, but rather by a flare-up of chronic 
obstructive pulmonary disease (COPD), which she attributed to her several years of cigarette 
smoking. She had taken daily smoke breaks with a friend and co-worker at the bank where she 
had worked for thirty years. Her career ended a year and a half before her most recent 
transplant, when she went on permanent disability leave, feeling pressured by her supervisors. 
The iatrogenic long-term effects of transplant medicine left her with declining eyesight and 
diminished health overall, and she had begun to make repeated mistakes. Janet explained: 
Work had been really bad. Really bad. I had to get out before they kicked me out. […] 
I was sick, and my eyes… I was making a lot of mistakes. And my boss said, ‘While I 
understand, we can’t have this’. So we got to the point where he said, ‘Other people 
are starting to watch your work’. I’ve been there thirty some years, and you know, your 
job’s on the line. I called [my doctor] and said, ‘I need your written report […] that I 
can’t work anymore now’. And he did. The following morning, there was a fax there 
[Janet begins to cry]… And that was a Friday, so I just worked that last day.  
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Successful transplants enabled Janet to build a career, but the complications of transplant-
related medicine also facilitated her career’s end. In other words, Janet’s work life was 
sustained but also constrained by decades of transplant living. 
Though they no longer socialize at work, and the sociality of smoking no longer plays an 
immediate role in their bond, Janet’s friend and former co-worker remained an ongoing, 
important node in Janet’s web of support. They still get together at a local bar once a week to 
play what Janet calls ‘old lady bowling’ on a video game console. It was this same friend who 
brought Janet to the hospital for her most recent transplant and looked in on Janet in the days 
following the procedure.  
This was critically important because transplant recipients spend little time recovering in 
hospital before they are discharged. Shorter hospital stays may be made possible by 
refinements in medical practices, but they are made imperative by health institutions looking 
to cut costs in a market-based, profit-driven US health care system. In the absence of a more 
comprehensive public safety net, it falls to individuals to bridge the gaps. Janet’s ability to live, 
work, and develop this close friendship would not have existed without transplant medicine. 
But given that Janet would be sent home so soon after the surgery, transplantation might have 
been perilous without the care of her friend.  
Thus, friendship, employment, health care policy, and state-of-the-art biomedicine all anchor 
these interwoven threads comprising Janet’s lived experience. To this list, we must also add 
kinship and family life. Janet had married, but divorced her husband when their son was five 
years old. Left in a precarious financial situation, she and her son moved to a trailer park, 
which Janet considered an ideal setting to mother a child because it would allow him several 
freedoms. Her desire for a particular kind of daily family life also posed risks to her health. 
… because then I could take a swing set, and if he screamed and yelled or, you know, 
was being a kid, there wouldn’t be somebody bumping a broom on the ceiling of an 
apartment. [….] And they had a swimming pool and tennis courts, and a playground 
area. And the pool was wonderful, of course, but, well, skin cancer… You can tell just 
right where my swimming suit sits and where my skin was damaged. 
Years of immunosuppression can leave transplant recipients more prone to some forms of 
skin cancer. Janet’s pursuit of an idyllic and affordable childhood for her son meant she spent 
long hours in the sun at the pool and playground. Over time, then, the medication regimen 
that kept her well enough to raise a child also transformed time outdoors into amplified risks 
to her health. It also precipitated further medical intervention: to remove the cancerous cells, 
Janet had to undergo a long and uncomfortable series of chemical skin peels under the close 
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supervision of a dermatologist. Her skin cancer, then, was a site for the confluence of 
biomedicine’s promise and biomedicine’s perils.  
Rather than extricating recipients from the tangles of illness, a successful transplant makes 
ongoing medical oversight nearly inevitable. This supports scholarly observations that the 
increasing dominance of medical therapies weaves patients and loved ones into ‘cycles of 
surveillance and care’ (Wolf-Meyers 2014, 155). But medical surveillance and care are, in 
practice, also fragmented and partial. They are cross-cut by the practical necessities of everyday 
life, particularly within the patchwork-style US system where individuals are made privately 
responsible for financial constraints. 
For example, upon approaching her third kidney transplant, Janet’s bone marrow ceased 
making blood cells, and her doctor prescribed injections of Procrit (a brand name for epoetin 
alfa). Safe use of this medication requires regular monitoring through blood tests. But the costs 
of frequent office visits add up quickly. This posed a problem for Janet, for whom finances 
were a persistent worry. To avoid the mounting office visit charges, Janet decided to self-
administer the injections:  
I was giving myself the injections and getting the lab work done, and the lab report 
would go to the doctor and they would decide how much to do the next time. It was 
not working well at all. I wasn’t getting my labs necessarily when I was supposed to… 
When I first started getting the shots and I was getting the lab work done and the report 
was going to the transplant office, apparently nobody was looking at it, because when 
I went to see the doctor, which I was only seeing the nephrologist every year, I think, 
and he looked at [my hemoglobin level] and he said, ‘It’s twenty-two. You could have 
a stroke sitting here right now’.  
Janet’s experiences illustrate the burdens and risks borne by recipients as they live the tensions 
between countervailing domains. Here, those domains include medically necessary 
monitoring, the high costs of US health care, and the disjointed system through which it is 
accessed. She minds the gaps through attempts to self-care, but her attempts are foiled by the 
very domains she is navigating. She is living with transplant and all that it brings, but also is 
never quite beyond jeopardy. 
Imbrications and continuities 
Transplantation relies on imbrications of separate entities: the overlapping of flesh, grafted 
from one person to another. Even the surgical closing of a wound by overlapping successive 
layers of tissue is itself an imbrication. And transplantation likewise necessitates the 
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overlapping of sociocultural domains (homes and hospitals, life and death, illness and healing, 
biomedicine and daily life) and lives (donors and recipients, patients and caregivers). But the 
transplant endeavor also depends on those imbrications to eventually become integrations. For 
recipients, tissues fuse, incisions heal, and biomedicine and daily life weave together. 
As Janet’s experiences demonstrate, this overlaying also comes with iatrogenic realities: the 
multiple complications that long-term recipients must navigate. Poorly equipped to address 
sociocultural complexities, transplant medicine instead looks toward more familiar frontiers 
as it pursues an end to its potentially negative health consequences. This is exemplified by 
recent experimental attempts to couple bone marrow stem cell transplantation with kidney 
transplantation to induce ‘immunological tolerance’ in recipients: transplanting the donor’s 
immune system along with the donor’s solid organ would remove the risk of rejection and 
immunosuppressants would no longer be necessary (Chen et al. 2016). Investigational 
developments in 3D printing may also be used to ‘print’ transplantable organs using a patient’s 
own cells, theoretically eliminating the risks of graft rejection along with the perennial shortage 
in donated organs (Hann et al. 2019). Such futuristic pursuits overlap with enduring ideals of 
progress and promises of renewal long woven into biotechnological development (Abel 2013, 
2). They resonate with other powerful currents in transplant-related discourse, which liken 
transplants to cures: an end to illness and the beginning of life beyond its reaches. 
As Matthew Wolf-Meyer (2014, 155) notes, cures have an ‘implicit linear trajectory’; they 
‘follow a longstanding Western interest in transcendence’ and ‘offer a final release from woes’ 
(ibid., 146). The transplant endeavor lends itself to public framing as a linear series of ‘events’: 
the ‘brain death’ of an organ donor (see Lock 2002), a very ill individual receiving ‘the call’ 
when an organ becomes available, the act of surgery. On their surface, the period ‘before 
transplant’ and the period ‘after transplant’ would seem clearly delineated and distinct. The 
ethnographic realities I have described here, however, suggest something else. After one 
receives a grafted organ, one might be better described as ‘with-’ rather than ‘post-’ transplant.  
Indeed, Janet’s experiences bring to light the mismatch between imaginings of transplant as 
‘cure’ and the realities of living with transplant. Instead of manifesting life ‘after illness’, 
transplant living comes into being through the rich interconnections of kinship, friendship, work, 
leisure, and home life, and through their persistent tensions with ongoing biomedical 
intervention – the myriad stakes involved in what Lenore Manderson and Carolyn Smith-
Morris (2010, 18) refer to as ‘lived experiences of continuity’. No less, transplant living is 
deeply shaped by the policy and political economic contexts woven throughout. Rather than 
as a cure, transplantation might be more accurately understood as a recursive arrangement of 
‘therapies’ (again, see Wolf-Meyer 2014, 155), which demand that patients and loved ones 
successfully manage a lasting tether to medical care. Life after transplant inflects life before 
Living with transplant 
 
 
 
 
90 
transplant, but does not so easily mark a new beginning as is suggested by the ubiquitous 
metaphors of rebirth, ‘new life’ or – to underscore the theme of this issue – an ‘after’ to illness. 
To conclude, I highlight questions inspired by the focus of this special issue: how do we 
understand the lifeworld and experiences of Janet, who has followed a thoroughly 
recognizable path in the American context, and who also has been repeatedly situated in 
relation to the pursuits of curative biomedicine? What does it mean to be a mother, a daughter, 
a friend, an employee while simultaneously remaining a patient (an inpatient, an outpatient, a 
pediatric patient, a surgical patient, a transplant patient, etc.), both enabled and constrained by 
therapeutic regimes, and never quite beyond illness? How do we account for enduring tethers 
to biomedicine without slippage toward the biomedical-centrism we are rightly cautioned to 
challenge (Manderson and Smith-Morris 2010, 6)?  
In other words, the orienting questions of this collection push us not merely to ask, ‘What 
happens after illness?’, but also to wonder, ‘What do we see when we look beyond illness as a 
privileged category in medical anthropology?’. Indeed, Janet’s experiences seem to insist that 
illness can hardly be erased, neither empirically nor conceptually. Because illness is always lived 
in tension with other domains of lived experience, it is best analyzed and theorized within 
these tensions as well. 
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